Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
J Neuroimaging. 2011 Jul;21(3):247-50. doi: 10.1111/j.1552-6569.2010.00494.x. Epub 2011 Jan 31.
Stroke is one of the most feared complications after cardiac catheterization. Endovascular treatment combining mechanical and pharmacological therapy has been reported as an effective treatment option in selected patients with acute stroke due to large-vessel occlusion. Little is known about safety and clinical outcome when this approach is utilized in cardiac catheterization associated strokes.
We analyzed clinical and radiological characteristics and outcomes in the endovascular acute stroke treatment databases from two University Hospitals from July 2006 to December 2008 (Cleveland Clinic Foundation) and September 1999 and December 2008 (UPMC Presbyterian hospital), respectively. Of a total of 419 acute stroke interventions, 14 (3.34%) were identified as strokes during or immediately after cardiac catheterization. The mean age was 71 ± 7 years; eight were women (57.1%). Mean National Institute of Health Stroke Scale was 17 (±7.6). Four patients underwent intravenous thrombolysis followed by intraarterial intervention. Median time to treatment was 240 minutes from last time seen normal (range 66-1,365 minutes). Seven patients (50%) had a favorable outcome (modified Rankin Scale [mRS]≤ 2). In-patient mortality was 42%.
In acute strokes following cardiac catheterization, multimodal endovascular therapy is safe and feasible and despite a high mortality is associated with a higher than expected rate of favorable outcomes compared to the natural history of the disease. Despite a significant proportion of patients developing symptoms in hospitals where neurointerventions are available, the median time to treatment was longer than expected. Future efforts should focus on faster implementation of recanalization therapies for this form of acute stroke.
中风是心脏导管检查后最令人恐惧的并发症之一。在某些特定的大血管闭塞性急性中风患者中,结合机械和药物治疗的血管内治疗已被证明是一种有效的治疗选择。然而,对于在心脏导管检查相关中风中使用这种方法的安全性和临床结果,人们知之甚少。
我们分析了分别来自两所大学医院(克利夫兰诊所基金会和匹兹堡大学医学中心长老会医院)的血管内急性中风治疗数据库中的临床和影像学特征及结果,时间范围分别为 2006 年 7 月至 2008 年 12 月(克利夫兰诊所基金会)和 1999 年 9 月至 2008 年 12 月。在总共 419 例急性中风介入治疗中,有 14 例(3.34%)被确定为心脏导管检查过程中或之后立即发生的中风。平均年龄为 71±7 岁,8 例为女性(57.1%)。平均 NIHSS 评分为 17(±7.6)。4 例患者接受了静脉溶栓治疗,随后进行了动脉内介入治疗。从最后一次正常时间到治疗的中位时间为 240 分钟(范围为 66-1365 分钟)。7 例(50%)患者的预后良好(mRS≤2)。住院死亡率为 42%。
在心脏导管检查后的急性中风中,多模式血管内治疗是安全可行的,尽管死亡率较高,但与疾病的自然病程相比,其预后良好的比例高于预期。尽管有相当一部分患者在有神经介入治疗的医院出现症状,但治疗的中位时间长于预期。未来的研究应集中于更快地实施这种急性中风的再通治疗。